JPS6111205B2 - - Google Patents

Info

Publication number
JPS6111205B2
JPS6111205B2 JP53079435A JP7943578A JPS6111205B2 JP S6111205 B2 JPS6111205 B2 JP S6111205B2 JP 53079435 A JP53079435 A JP 53079435A JP 7943578 A JP7943578 A JP 7943578A JP S6111205 B2 JPS6111205 B2 JP S6111205B2
Authority
JP
Japan
Prior art keywords
fluorouracil
compound
antitumor effect
group
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP53079435A
Other languages
English (en)
Japanese (ja)
Other versions
JPS557231A (en
Inventor
Setsuo Fujii
Norio Saimi
Setsuo Takeda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Priority to JP7943578A priority Critical patent/JPS557231A/ja
Publication of JPS557231A publication Critical patent/JPS557231A/ja
Publication of JPS6111205B2 publication Critical patent/JPS6111205B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP7943578A 1978-06-29 1978-06-29 Agent for promoting anti-tumor activity Granted JPS557231A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP7943578A JPS557231A (en) 1978-06-29 1978-06-29 Agent for promoting anti-tumor activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7943578A JPS557231A (en) 1978-06-29 1978-06-29 Agent for promoting anti-tumor activity

Publications (2)

Publication Number Publication Date
JPS557231A JPS557231A (en) 1980-01-19
JPS6111205B2 true JPS6111205B2 (fr) 1986-04-01

Family

ID=13689794

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7943578A Granted JPS557231A (en) 1978-06-29 1978-06-29 Agent for promoting anti-tumor activity

Country Status (1)

Country Link
JP (1) JPS557231A (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1570555A (en) * 1977-04-05 1980-07-02 Taiho Pharmaceutical Co Ltd Anti-cancer composition

Also Published As

Publication number Publication date
JPS557231A (en) 1980-01-19

Similar Documents

Publication Publication Date Title
US20040102461A1 (en) Method of treating cancer by conjunctive theraphy with 2'-halomethylidene derivatives and a s-phase or m-phase specific antineoplastic agent
EP0495776A1 (fr) Complexes stabilises d'oxyde nitrique-amines primaires utiles comme agents cardiovasculaires.
US4328229A (en) Anti-cancer composition for delivering 5-fluorouracil to cancer tissues
US20140371193A1 (en) Organometallic complexes as therapeutic agents
IE57675B1 (en) 5-pyrimidinecarboxamides and thiocarboxamides and treatment of leukemia and tumors therewith
AU2004220205B2 (en) Antitumor effect potentiator and antitumor agent
US4652570A (en) Anti-cancer composition for delivering 5-fluorouracil
Jondorf et al. Increased lifespan of leukemic mice treated with drugs related to (–)-emetine
KR950001040B1 (ko) 티오우레아 유도체 및 이를 함유하는 항균제 및 항궤양제
EP0500953B1 (fr) Potentialisateur d'effets antineoplasique et agent antineoplasique
US4719213A (en) Anti-cancer composition for delivering 5-fluorouracil
JPS6111205B2 (fr)
JPWO1992004028A1 (ja) 抗腫瘍効果増強剤及び抗腫瘍剤
US5534513A (en) Antitumor potentiator and antitumor composition
JPS62919B2 (fr)
ZA200700134B (en) Antitumor effect fortifier, antitumor agent and method of therapy for cancer
JPWO2002042284A1 (ja) ジベンゾスベラニルピペラジン誘導体および該誘導体を含む薬剤耐性克服剤
GB1597882A (en) Injectable pharmaceutical compositions comprising pteridine derivatives
US20110136810A1 (en) Antitumor agent, kit and method of treating cancer
JP4267447B2 (ja) 細胞増殖抑制作用を有するランタン化合物
EP0120019A1 (fr) Composition pharmaceutique a action cytostatique.
EP0331917B1 (fr) Dialcoyl disélénides à activité antinéoplastique
JPS5953885B2 (ja) 抗腫瘍剤組成物
JPH0120128B2 (fr)
JPH06279287A (ja) 癌転移抑制剤